A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants
Clinical trial NCT05477095 · COMPLETED
Trial details
- NCT number
- NCT05477095
- Sponsor
- Vaxxinity, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-06
- Primary completion
- 2023-10-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.